Blood Karyotyping, Anti-Müllerian Hormone Level, SRY Gene, and Clinical Evaluation in Patients Reared as Female Presented with Müllerian Duct Agenesis. Journal of Carcinogenesis, [S. l.], v. 24, n. 3, p. 387–404, 2025. DOI: 10.64149/J.Carcinog.24.3.387-404. Disponível em: https://carcinogenesis.com/index.php/JOC/article/view/809. Acesso em: 26 dec. 2025.